Andrea Wang-Gillam, MD on Phase I Study of Defactinib Combined with Pembrolizumab and Gemcitabine #AACR #AACR20 @WUSTLmed

Andrea Wang-Gillam, MD on Phase I Study of Defactinib Combined with Pembrolizumab and Gemcitabine #AACR #AACR20 @WUSTLmed

User Photo
Cancer-News

8 months
54 Views
Share
Want to watch this again later?
Sign in to add this video to a playlist. Login
0 0
Category:
Description:

Andrea Wang-Gillam, MD, PhD of Washington University School of Medicine @WUSTLmed discusses the phase I study of defactinib combined with pembrolizumab and gemcitabine in patients with advanced cancer presented at this year's AACR Annual Meeting.

Up Next Autoplay
>